Literature DB >> 2450088

Gliotoxin causes oxidative damage to plasmid and cellular DNA.

R D Eichner1, P Waring, A M Geue, A W Braithwaite, A Müllbacher.   

Abstract

The cytotoxic effects of gliotoxin (Müllbacher, A., and Eichner, R. D. (1984) Proc. Natl. Acad. Sci. U.S.A. 81, 3835-3837), a fungal secondary metabolite, and related epipolythiodioxopiperazines have been investigated using plasmid and eukaryotic DNA. Incubation of the dithiol derivative of these compounds with DNA and Fe3+ is sufficient to cause single- and double-stranded breaks as determined by neutral agarose gel electrophoresis. The disulfide form is inactive except in the presence of a suitable reducing agent, such as reduced glutathione, dithiothreitol, or reduced pyridine coenzymes. The autooxidation of these dithiols produces reducing equivalents as evidenced by (i) the production of H2O2 and (ii) the generation of thiobarbituric acid reactive products when incubated with deoxyribose. The latter process is inhibited by ethanol and desferrioxamine. The DNA damage is abrogated by metal chelators and catalase. We conclude that the antiproliferative action of gliotoxin may be caused by DNA damage effected by reactive oxygen species or other radicals generated through redox cycling.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450088

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Fungal metabolite gliotoxin targets flavocytochrome b558 in the activation of the human neutrophil NADPH oxidase.

Authors:  Satoshi Nishida; Lucia S Yoshida; Takashi Shimoyama; Hiroyuki Nunoi; Toshihiro Kobayashi; Shohko Tsunawaki
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Aspergillus cyclooxygenase-like enzymes are associated with prostaglandin production and virulence.

Authors:  Dimitrios I Tsitsigiannis; Jin-Woo Bok; David Andes; Kristian Fog Nielsen; Jens C Frisvad; Nancy P Keller
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  A Modular Construction of Epidithiodiketopiperazines.

Authors:  Thomas N Snaddon; Toya D Scaggs; Colin M Pearson; James W B Fyfe
Journal:  Org Lett       Date:  2019-06-11       Impact factor: 6.005

4.  Apoptosis induced by the fungal pathogen gliotoxin requires a triple phosphorylation of Bim by JNK.

Authors:  A Geissler; F Haun; D O Frank; K Wieland; M M Simon; M Idzko; R J Davis; U Maurer; C Borner
Journal:  Cell Death Differ       Date:  2013-07-05       Impact factor: 15.828

Review 5.  Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis.

Authors:  Taylor R T Dagenais; Nancy P Keller
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

Review 6.  Epidithiodioxopiperazines. occurrence, synthesis and biogenesis.

Authors:  Timothy R Welch; Robert M Williams
Journal:  Nat Prod Rep       Date:  2014-10       Impact factor: 13.423

7.  Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium.

Authors:  R Amitani; G Taylor; E N Elezis; C Llewellyn-Jones; J Mitchell; F Kuze; P J Cole; R Wilson
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Isolation and identification of Aspergillus fumigatus mycotoxins on growth medium and some building materials.

Authors:  Susanna M Nieminen; Riikka Kärki; Seppo Auriola; Mika Toivola; Hartmut Laatsch; Reino Laatikainen; Anne Hyvärinen; Atte Von Wright
Journal:  Appl Environ Microbiol       Date:  2002-10       Impact factor: 4.792

9.  The mtfA transcription factor gene controls morphogenesis, gliotoxin production, and virulence in the opportunistic human pathogen Aspergillus fumigatus.

Authors:  Timothy D Smith; Ana M Calvo
Journal:  Eukaryot Cell       Date:  2014-04-11

10.  VeA regulates conidiation, gliotoxin production, and protease activity in the opportunistic human pathogen Aspergillus fumigatus.

Authors:  Sourabh Dhingra; David Andes; Ana M Calvo
Journal:  Eukaryot Cell       Date:  2012-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.